-
-
-
-
-
-
-
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
-
-
-
-
-
-
-
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds
-
-
-
-
-
-
-
FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
-
-
-
-
-
-
-
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
-
-
-
-
-
-
-
QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems
-
-
-
-
-
-
-
Thermo Fisher Scientific (TMO) Confirms Offer to Acquire QIAGEN (QGEN) Shares Expires on August 10
-
-
-
-
-
-
-
Qiagen (QGEN) Announces Shareholder Approve All Agenda Items Related to Thermo Fisher (TMO) Deal
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

